title: Cost effectiveness of roxithromycin versus cefaclor in Australia.
authors.forename: W G
authors.initials: WG
authors.lastname: Scott
authors.forename: B C
authors.initials: BC
authors.lastname: Cooper
authors.forename: H M
authors.initials: HM
authors.lastname: Scott
authors.forename: M W
authors.initials: MW
authors.lastname: Tilyard
authors.forename: S M
authors.initials: SM
authors.lastname: Dovey
mesh_terms: D001315:Australia; D002433:Cefaclor / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005500:Follow-Up Studies; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000191:economics; D015575:Roxithromycin / Q000191:economics* / Q000627:therapeutic use; D016896:Treatment Outcome